Cepheid
Company profile
Converted/ClosedUnited Kingdom
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
FC023302- Status
- Converted/Closed
- Type
- Overseas company
- Incorporated
- —
- Jurisdiction
- —
- Registered office
- —
Classification
0 SIC codesNo SIC classification available.
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsA targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in IndonesiaActiveMRC · Research Grant · 2022-08-31 – 2026-11-30 · with 5 other participants£794,768whole project
A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in IndonesiaActive
MRC · Research Grant · 2022-08-31 – 2026-11-30 · with 5 other participants
£794,768
whole project
University Of OxfordleadBali Province AIDS CommissionCepheidMinistry of Health Republic of IndonesiaSpiritiaUnaids
A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in IndonesiaActiveMRC · Research Grant · 2022-08-31 – 2026-11-30 · with 5 other participants£794,768whole project
A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in IndonesiaActive
MRC · Research Grant · 2022-08-31 – 2026-11-30 · with 5 other participants
£794,768
whole project
University Of OxfordleadBali Province AIDS CommissionCepheidMinistry of Health Republic of IndonesiaSpiritiaUnaids
MICA: Radio+ TB trial development: Determining the optimal regimen for bacteriologically negative, radiographically apparent TB diagnosed usingnewtestMRC · Research Grant · 2021-02-01 – 2022-12-31 · with 8 other participants£202,035whole project
MICA: Radio+ TB trial development: Determining the optimal regimen for bacteriologically negative, radiographically apparent TB diagnosed usingnewtest
MRC · Research Grant · 2021-02-01 – 2022-12-31 · with 8 other participants
£202,035
whole project
University College LondonleadCepheidFoundation for Innovative New Diagnostics (FIND)Ludwig-Maximilians-Universität MünchenMalawi Liverpool Wellcome ProgrammeNew York UniversityUniversity College LondonUniversity of LeicesterWorld Health Organization (WHO)
Mica: Eradicate Hiv-1: Targeting The Hiv-1 Reservoir With New Immunotherapeutic StrategiesMRC · Fellowship · 2014-09-29 – 2020-12-31 · with 9 other participants£1,468,100whole project
Mica: Eradicate Hiv-1: Targeting The Hiv-1 Reservoir With New Immunotherapeutic Strategies
MRC · Fellowship · 2014-09-29 – 2020-12-31 · with 9 other participants
£1,468,100
whole project
University Of OxfordleadAIDS Clinical Trials Group (ACTG)CepheidChelsea and Westminster Hospital NHS Foundation TrustHarvard UniversityImperial College LondonImperial College School of MedicineKing'S College LondonRockefeller UniversitySt Thomas' Hospital